MedTrace Logo

Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis

NCT03519438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-05-20

No results posted yet for this study

Summary

The aim of this study is to examine alterations in the skin microbiome that occur during radiation therapy. The study design will examine changes secondary to ionizing radiation, and correlate these changes with the development and severity of radiation dermatitis. The goal is to improve understanding of the mechanism of radiation dermatitis.

Conditions

Interventions

OTHER

Mepitel

Mepitel film will be placed on 3/4 of treatment field to protect from radiation dermatitis

Sponsors & Collaborators

Principal Investigators

  • Kimberly Corbin, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2019-11-25
Completion
2019-11-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03519438 on ClinicalTrials.gov